Cargando…
[(18)F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis
PURPOSE: We evaluated myelin changes throughout the central nervous system in Multiple Sclerosis (MS) patients by using hybrid [(18)F]florbetapir PET-MR imaging. METHODS: We included 18 relapsing-remitting MS patients and 12 healthy controls. Each subject performed a hybrid [(18)F]florbetapir PET-MR...
Autores principales: | Carotenuto, Antonio, Giordano, Beniamino, Dervenoulas, George, Wilson, Heather, Veronese, Mattia, Chappell, Zachary, Polychronis, Sotirios, Pagano, Gennaro, Mackewn, Jane, Turkheimer, Federico E., Williams, Steven C. R., Hammers, Alexander, Silber, Eli, Brex, Peter, Politis, Marios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974490/ https://www.ncbi.nlm.nih.gov/pubmed/31637481 http://dx.doi.org/10.1007/s00259-019-04533-y |
Ejemplares similares
-
Impaired connectivity within neuromodulatory networks in multiple sclerosis and clinical implications
por: Carotenuto, Antonio, et al.
Publicado: (2020) -
Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson’s patients
por: Polychronis, Sotirios, et al.
Publicado: (2019) -
Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2019) -
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
por: Wilson, Heather, et al.
Publicado: (2022) -
Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)